tykhr
sign in
free sign up
Vertex Pharmaceuticals Inc
Biotechnology
Healthcare
VRTX
261 M shares
NASDAQ US
traded
09 Apr 2025
listed
no
open
460.02
52 week high
516.74
high
487.15
52 week low
396.64
low
452.00
growth
5.92 %
previous Close
472.37
P/E ratio
110
market cap
105 B
div yield
0
usd
Sep 2024
qoq
revenue
2.77 B
5.21 %
net incoming
1.05 B
129.09 %
eps
4.38 %
134.14 %
eps surprise
5.80 %
net profit margin
37.71 %
174.00 %
operating incoming
1.12 B
131.67 %
net change in cash
668 M
114.59 %
cash on hand
5.24 B
14.39 %
cost of revenue
393 M
5.57 %
top